BeingWell
Published in

BeingWell

Convalescent Plasma Is Hardly A “Breakthrough”

The data for convalescent plasma is not good

Photo by LuAnn Hunt on Unsplash

On August 23, the FDA issued an emergency use authorization for convalescent plasma for the treatment of severe COVID-19. The Trump Administration hailed convalescent plasma as a “breakthrough” treatment for COVID-19. That is a bit of a stretch.

--

--

--

A Medika Life Publication for the Medical Community

Recommended from Medium

Vaccinated and Boosted? Omicron Is Coming for Your Sanity.

Data story: India logs 238,018 new cases; positivity rate rises to 14.4%

COVID-19 Vaccination Pass: A Peek Behind the Curtain

COVID-19 and My Thoughts (6/3/2020)

What happens after Christmas?

COVID-19 in New York: Stanford volunteers provide care, support

Health Alert: Mask Mandate Continues in California Despite CDC Guidelines 5/17/21

Health Alert: Mask Mandate Continues in California Despite CDC Guidelines 5/17/21

A Stanford doctor’s COVID-19 experience: ‘It felt good to be recovered’ | Part 2

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dr. Hesham A. Hassaballa

Dr. Hesham A. Hassaballa

NY Times featured Pulmonary and Critical Care Specialist | Physician Leader | Author and Blogger | His latest book is “Code Blue,” a medical thriller.

More from Medium

My Predictions (And Hopes) For This Year’s Emmy Nominations: Week 3, Day 3

Why America won't be able to protect their children without better public services

Sad child

The (Temporary) Happiness of Being A Detroit Sports Fan

The life, displaced — what it’s like to be a Ukrainian stuck in the US because of the war.

Ukraine is the capital of brave people. Russia’s invasion of Ukraine.